InvestorsHub Logo
Followers 64
Posts 2029
Boards Moderated 0
Alias Born 10/31/2017

Re: Maverick0408 post# 438677

Wednesday, 01/26/2022 10:40:06 AM

Wednesday, January 26, 2022 10:40:06 AM

Post# of 704164
Maverick, spot on!

I have seen positions open now for way too long, and I don’t even want to elude to the salary and benefits packages we are talking about because I don’t feel any desire to explain. Suffices to say, skilled labor is incredibly tight in Biopharma.

Given all the progress and positive developments over the past 15 months, there is no way NWBO plans to go it alone in the United States, maybe UK and even Canada, but it cannot happen in the US. Our market is incredibly complex with liability everywhere. You need a huge machine of operations talent and this drug is very complex in its manufacturing and supply chain dynamics, not to mention the billing nuances of mixing medical and pharmacy benefits.

Partner or BO is coming shortly after approval which IIMO is pending.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News